Home/Filings/4/0001610618-25-000053
4//SEC Filing

Mineo Chrysa 4

Accession 0001610618-25-000053

CIK 0001610618other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 4:23 PM ET

Size

6.4 KB

Accession

0001610618-25-000053

Insider Transaction Report

Form 4
Period: 2025-06-02
Mineo Chrysa
Director
Transactions
  • Purchase

    Common Stock

    2025-06-02$21.71/sh+2,270$49,2812,270 total
  • Purchase

    Common Stock

    2025-06-03$23.44/sh+1,050$24,6143,320 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.365 to $23.52. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Issuer

Cidara Therapeutics, Inc.

CIK 0001610618

Entity typeother

Related Parties

1
  • filerCIK 0001575644

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:23 PM ET
Size
6.4 KB